ADARx Pharmaceuticals is a newly launched next-wave genetic medicine company focusing on oligonucleotide therapeutics for inhibition, degradation and base editing of mRNA transcripts. With RNA as the target of our drug discovery, we are capable of working on a wide range of diseases and are currently focusing on genetic, cardiometabolic, and central nervous system (CNS) diseases. We are driven by our mission to turn cutting-edge science into life-saving therapeutics and our desire to provide hope for patients with intractable disease.
We are well-financed with backup from a group of renowned VC funds, and our brand-new laboratory is located in San Diego, California.
Location: Canada
Employees: 11-50
Total raised: $321M
Founded date: 2019
Investors 5
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
| 13.08.2023 | TCG Crosso... | tcgcrossov... |
| 04.11.2023 | HBM Partne... | hbmpartner... |
| 10.03.2024 | Bain Capit... | baincapita... |
| 15.09.2021 | SR One | srone.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 10.08.2023 | Series C | $200M | - |
| 24.01.2023 | Series B | $46M | - |
| 09.08.2021 | - | $75M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 10.08.2023 | ADARx Pharmaceuticals closes $200M Series C round to advance... | - | connect.or... |
| 10.08.2023 | ADARx Pharmaceuticals Raises $200M in Series C Financing | ADARx Pharmaceuticals, Inc., a San Diego, CA-based clinical stage biotechnology company developing n... | finsmes.co... |
| 09.08.2023 | ADARx Pharmaceuticals Announces Oversubscribed $200 Million ... | - | tcgcrossov... |
| 30.01.2023 | 50 recently-funded startups to watch in 2023 | With the ongoing economic downturn and fear of a recession, tech startups have been hit hard as inve... | techstartu... |
| 24.01.2023 | California-based biotech company ADARx Pharmaceuticals raise... | SAN DIEGO — To accelerate its drug development pipeline as the firm’s first product approaches the c... | vcbay.news... |
| 23.01.2023 | Adarx Pharmaceuticals closes $46M Series B round to develop ... | - | connect.or... |
| 23.01.2023 | ADARx Pharmaceuticals Takes $46M | San Diego-based ADARx Pharmaceuticals has raised $46M in a Series B-1 funding, the company said on F... | socaltech.... |
| 20.01.2023 | ADARx Pharmaceuticals Inks $46M Series B-1 | SAN DIEGO, CA, ADARx Pharmaceuticals, a clinical stage biotechnology company, announced the close ... | vcnewsdail... |
| 20.01.2023 | ADARx Pharmaceuticals Raises $46M in Series B-1 Financing | ADARx Pharmaceuticals, a San Diego, CA-based clinical stage biotechnology company developing RNA-tar... | finsmes.co... |
| 14.09.2021 | Daily funding roundup - September 13th, 2021 | Numan raised $40M; Babyscripts landed $12M; Courier Health secured 4$M SpotOn: SpotOn is a San Franc... | vator.tv/n... |
Show more